The nuclear receptors Rev-erbs and RORs integrate circadian rhythms and metabolism

Diabetes and Vascular Disease Research

Volumn 5, Issue 2, 2008, Pages 82-88

  Duez, Hélène ^a,b   Staels, Bart ^a,b  

^a INSTITUT PASTEUR DE LILLE   (France)

^b UNIV LILLE   (France)

Author keywords

Biological clock; Cardiovascular disease; Circadian rhythm; Metabolic disorders; Nuclear receptor; Rev erb ; ROR

Indexed keywords

CELL NUCLEUS RECEPTOR; NUCLEAR RECEPTOR REV ERB ALPHA; NUCLEAR RECEPTOR ROR ALPHA;

ADIPOGENESIS; CIRCADIAN RHYTHM; HEART INFARCTION; HUMAN; LIPOPROTEIN METABOLISM; METABOLIC DISORDER; METABOLISM; NONHUMAN; REVIEW; STROKE; SUDDEN DEATH;

EID: 45249115128     PISSN: 14791641     EISSN: None     Source Type: Journal    
DOI: 10.3132/dvdr.2008.0014     Document Type: Review

References (91)

1. Aparicio NJ, Puchulu FE, Gagliardino JJ et al. Circadian variation of blood-glucose, plasma-insulin and human growth-hormone levels in response to an oral glucose-load in normal subjects. Diabetes 1974;23: 132-7.
2. Baker IA, Jarrett RJ. Diurnal variation in blood-sugar and plasma-insulin response to tolbutamide. Lancet 1972;2:945-7.
3. VanCauter E, Polonsky KS, Scheen AJ. Roles of circadian rhythmicity and sleep in human glucose regulation. Endocrine Reviews 1997;18: 716-38.
4. Van Cauter E, Desir D, Decoster C, Fery F, Balasse EO. Nocturnal decrease in glucose tolerance during constant glucose infusion. J Clin Endocrinol Metab 1989;69:604-11.
5. Castro Cabezas M, Halkes CJM, van Wijk JPH, Erkelens DW. Increased waist circumference: The link between insulin resistance and enhanced diurnal triglyceridemia? Diabetologia 2000;43:A170.
6. Schlierf G, Dorow E. Diurnal patterns of triglycerides, free fatty-acids, blood-sugar, and insulin during carbohydrate-induction in man and their modification by nocturnal suppression of lipolysis. J Clin Invest 1973;52:732-40.
7. Romon M, Le Fur C, Lebel P, Edme JL, Fruchart JC, Dallongeville J. Circadian variation of postprandial lipemia. Am J Clin Nutr 1997;65: 934-40.
8. Boden G, Chen XH, Polansky M. Disruption of circadian insulin secretion is associated with reduced glucose uptake in first-degree relatives of patients with type 2 diabetes. Diabetes 1999;48:2182-8.
9. HagstromToft E, Bolinder J, Ungerstedt U, Arner P. A circadian rhythm in lipid mobilization which is altered in IDDM. Diabetologia 1997;40: 1070-8.
10. Di Lorenzo L, De Pergola G, Zocchetti C et al. Effect of shift work on body mass index: results of a study performed in 319 glucose-tolerant men working in a Southern Italian industry. Internat J Obesity 2003; 27:1353-8.
11. Karlsson B, Knutsson A, Lindahl B. Is there an association between shift work and having a metabolic syndrome? Results from a population based study of 27,485 people. Occup Environ Med 2001;58:747-52.
12. Gottlieb DJ, Punjabi NM, Newman AB et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 2005;165:863-7.
13. Chaput JP, Brunet M, Tremblay A. Relationship between short sleeping hours and childhood overweight/obesity: results from the 'Quebec en Forme' Project. Int J Obes (Lond) 2006;30:1080-5.
14. Kawachi I, Colditz GA, Stampfer MJ et al. Prospective study of shift work and risk of coronary heart disease in women. Circulation 1995; 92:3178-82.
15. Gangwisch JE, Malaspina D, Boden-Albala B, Heymsfield SB. Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep 2005;28:1289-96.
16. Gangwisch JE, Heymsfield SB, Boden-Albala B et al. Short sleep duration as a risk factor for hypertension - Analyses of the first national health and nutrition examination survey. Hypertension 2006;47:833-9.
17. Holmback U, Forslund A, Lowden A et al. Endocrine responses to nocturnal eating - possible implications for night work. Eur J Nutr 2003;42: 75-83.
18. Laposky AD, Bass J, Kohsaka A, Turek FW. Sleep and circadian rhythms: Key components in the regulation of energy metabolism. FEBS Lett 2008;582:142-51.
19. Ando H, Yanagihara H, Hayashi Y et al. Rhythmic messenger ribonucleic acid expression of clock genes and adipocytokines in mouse visceral adipose tissue. Endocrinology 2005;146:5631-6.
20. Calvani M, Scarfone A, Granato L et al. Restoration of adiponectin pulsatility in severely obese subjects after weight loss. Diabetes 2004;53: 939-47.
21. Yildiz BO, Suchard MA, Wong ML, McCann SM, Licinio J. Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. Proc Natl Acad Sci USA 2004;101:10434-9.
22. Muller JE, Tofler GH. Circadian variation and cardiovascular-disease. N Engl J Med 1991;325:1038-9.
23. Ridker PM, Manson JE, Buring JE, Muller JE, Hennekens CH. Circadian variation of acute myocardial-infarction and the effect of low-dose aspirin in a randomized trial of physicians. Circulation 1990;82:897-902.
24. Manfredini R, Portaluppi F, Zamboni P, Salmi R, Gallerani M. Circadian variation in spontaneous rupture of abdominal aorta. Lancet 1999; 353:643-4.
25. Young ME, Razeghi P, Cedars AM, Guthrie PH, Taegtmeyer H. Intrinsic diurnal variations in cardiac metabolism and contractile function. Circ Res 2001;89:1199-208.
26. Rudic RD, Curtis AM, Cheng Y, FitzGerald G. Peripheral clocks and the regulation of cardiovascular and metabolic function. Circadian Rhythms 2005;393:524-39.
27. Young ME, Razeghi P, Taegtmeyer H. Clock genes in the heart - Characterization and attenuation with hypertrophy. Circ Res 2001;88: 1142-50.
28. Zulch KJ, Hossmann V. 24-hour rhythm of human blood pressure. Dtsch Med Wochenschr 1967;92:567-72.
29. Shaw JA, Chin-Dusting JPF, Kingwell BA, Dart AM. Diurnal variation in endothelium-dependent vasodilatation is not apparent in coronary artery disease. Circulation 2001;103:806-12.
30. Turek FW, Joshu C, Kohsaka A et al. Obesity and metabolic syndrome in circadian Clock mutant mice. Science 2005;308:1043-5.
31. Rudic RD, McNamara P, Curtis AM et al. BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis. PLoS Biol 2004;2:e377.
32. DeBruyne JP, Weaver DR, Reppert SM. CLOCK and NPAS2 have overlapping roles in the suprachiasmatic circadian clock. Nature Neuroscience 2007;10:543-5.
33. Gachon F, Nagoshi E, Brown SA, Ripperger J, Schibler U. The mammalian circadian timing system: from gene expression to physiology. Chromosoma 2004;113:103-12.
34. Triqueneaux G, Thenot S, Kakizawa T et al. The orphan receptor Rev-erbalpha gene is a target of the circadian clock pacemaker. J Mol Endocrinol 2004;33:585-608.
35. Preitner N, Damiola F, Lopez-Molina L et al. The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 2002;110:251-60.
36. Kakizawa T, Nishio S, Triqueneaux G, Bertrand S, Rambaud J, Laudet V. Two differentially active alternative promoters control the expression of the zebrafish orphan nuclear receptor gene Rev-erbalpha. J Mol Endocrinol 2007;38:555-68.
37. Guillaumond F, Dardente H, Giguere V, Cermakian N. Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. J Biol Rhythms 2005;20:391-403.
38. Akashi M, Takumi T. The orphan nuclear receptor RORalpha regulates circadian transcription of the mammalian core-clock Bmal1. Nat Struct Mol Biol 2005;12:441-8.
39. Sato TK, Panda S, Miraglia LJ et al. A functional genomics strategy reveals Rora as a component of the mammalian circadian clock. Neuron 2004;43:527-37.
40. Liu C, Li SM, Liu TH, Borjigin J, Lin JD. Transcriptional coactivator PGC-1a integrates the mammalian clock and energy metabolism. Nature 2007;447:477-81.
41. Honma S, Kawamoto T, Takagi Y et al. Dec1 and Dec2 are regulators of the mammalian molecular clock. Nature 2002;419:841-4.
42. Mitsui S, Yamaguchi S, Matsuo T, Ishida Y, Okamura H. Antagonistic role of E4BP4 and PAR proteins in the circadian oscillatory mechanism. Genes Dev 2001;15:995-1006.
43. Ueda HR, Hayashi S, Chen WB et al. System-level identification of transcriptional circuits underlying mammalian circadian clocks. Nature Genetics 2005;37:187-92.
44. Eide EJ, Vielhaber EL, Hinz WA, Virshup DM. The circadian regulatory proteins BMAL1 and cryptochromes are substrates of casein kinase I epsilon. J Biol Chem 2002;277:17248-54.
45. Lin JM, Kilman VL, Keegan K et al. A role for casein kinase 2 alpha in the Drosophila circadian clock. Nature 2002;420:816-20.
46. Gallego M, Virshup DM. Post-translational modifications regulate the ticking of the circadian clock. Nat Rev Mol Cell Biol 2007;8:139-48.
47. Yin L, Wang J, Klein PS, Lazar MA. Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock. Science 2006;311:1002-05.
48. Etchegaray JP, Lee C, Wade PA, Reppert SM. Rhythmic histone acetylation underlies transcription in the mammalian circadian clock. Nature 2003;421:177-82.
49. Damiola F, Le Minh N, Preitner N, Kornmann B, Fleury-Olela F, Schibler U. Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus. Genes Dev 2000;14:2950-61.
50. Panda S, Antoch MP, Miller BH et al. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 2002;109:307-20.
51. Storch KF, Lipan O, Leykin I et al. Extensive and divergent circadian gene expression in liver and heart. Nature 2002;417:78- 83.
52. Rudic RD, McNamara P, Reilly D et al. Bioinformatic analysis of circadian gene oscillation in mouse aorta. Circulation 2005;112:2716-24.
53. Migita H, Morser J, Kawai K. Rev-erbalpha upregulates NF-kappaB-responsive genes in vascular smooth muscle cells. FEBS Lett 2004; 561:69-74.
54. Lazar MA, Hodin RA, Darling DS, Chin WW. A novel member of the thyroid/steroid hormone receptor family is encoded by the opposite strand of the rat c-erbA alpha transcriptional unit. Mol Cell Biol 1989; 9:1128-36.
55. Dumas B, Harding HP, Choi HS et al. A new orphan member of the nuclear hormone receptor superfamily closely related to Rev-Erb. Mol Endocrinol 1994;8:996-1005.
56. Forman BM, Chen J, Blumberg B et al. Cross-talk among ROR alpha 1 and the Rev-erb family of orphan nuclear receptors. Mol Endocrinol 1994;8:1253-61.
57. Retnakaran R, Flock G, Giguere V. Identification of Rvr, a novel orphan nuclear receptor that acts as a negative transcriptional regulator. Mol Endocrinol 1994;8:1234-44.
58. Yin L, Wu N, Curtin JC et al. Rev-erbα, a heme sensor that coordinates metabolic and circadian pathways. Science 2007;18:1786-9.
59. Raghuram S, Stayrook KR, Huang P et al. Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta. Nat Struct Mol Biol 2007;14:1207-13.
60. Kallen JA, Schlaeppi JM, Bitsch F et al. X-ray structure of the hRORalpha LBD at 1.63 A. Structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha. Structure (Camb) 2002;10:1697-707.
61. Harding HP, Lazar MA. The monomer-binding orphan receptor Rev-Erb represses transcription as a dimer on a novel direct repeat. Mol Cell Biol 1995;15:4791-802.
62. Harding HP, Lazar MA. The orphan receptor Rev-ErbA alpha activates transcription via a novel response element. Mol Cell Biol 1993;13: 3113-21.
63. Adelmant G, Begue A, Stehelin D, Laudet V. A functional Rev-erb alpha responsive element located in the human Rev-erb alpha promoter mediates a repressing activity. Proc Natl Acad Sci USA 1996;93:3553-8.
64. Raspe E, Mautino G, Duval C et al. Transcriptional regulation of human Rev-erbalpha gene expression by the orphan nuclear receptor retinoic acid-related orphan receptor alpha. J Biol Chem 2002;277:49275-81.
65. Gervois P, Chopin-Delannoy S, Fadel A et al. Fibrates increase human REV-ERBalpha expression in liver via a novel peroxisome proliferator-activated receptor response element. Mol Endocrinol 1999;13:400-09.
66. Fontaine C, Dubois G, Duguay Y et al. The orphan nuclear receptor Rev-Erbalpha is a peroxisome proliferator-activated receptor (PRAR) gamma target gene and promotes PRARgamma-induced adipocyte differentiation. J Biol Chem 2003;278:37672-80.
67. Vu-Dac N, Chopin-Delannoy S, Gervois P et al. The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates. J Biol Chem 1998;273:25713-20.
68. Raspe E, Duez H, Mansen A et al. Identification of Rev-erbalpha as a physiological repressor of apoC-III gene transcription. J Lipid Res 2002; 43:2172-9.
69. Duez H, Mansen A, Fievet C et al. Rev-erba: an orphan nuclear receptor regulating lipoprotein metabolism. Atherosclerosis 2000;149:229-38.
70. Vu-Dac N, Gervois P, Grotzinger T et al. Transcriptional regulation of apolipoprotein A-I gene expression by the nuclear receptor RORalpha. J Biol Chem 1997;272:22401-04.
71. Raspe E, Duez H, Gervois P et al. Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor RORalpha. J Biol Chem 2001;276:2865-71.
72. Mamontova A, Seguret-Mace S, Esposito B et al. Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha. Circulation 1998;98:2738-43.
73. Pircher P, Chomez P, Yu F, Vennstrom B, Larsson L. Aberrant expression of myosin isoforms in skeletal muscles from mice lacking the rev-erbAalpha orphan receptor gene. Am J Physiol Regul Integr Comp Physiol 2005;288:R482-R490.
74. Ramakrishnan SN, Lau P, Burke LJ, Muscat GE. Rev-erbbeta regulates the expression of genes involved in lipid absorption in skeletal muscle cells: evidence for cross-talk between orphan nuclear receptors and myokines. J Biol Chem 2005;280:8651-9.
75. Lau P, Nixon SJ, Parton RG, Muscat GEO. ROR alpha regulates the expression of genes involved in lipid homeostasis in skeletal muscle cells - Caveolin-3 and CPT-1 are direct targets of ROR. J Biol Chem 2004;279:36828-40.
76. Chawla A, Lazar MA. Induction of Rev-ErbA alpha, an orphan receptor encoded on the opposite strand of the alpha-thyroid hormone receptor gene, during adipocyte differentiation. J Biol Chem 1993;268: 16265-9.
77. Barish GD, Downes M, Alaynick WA et al. A nuclear receptor atlas: macrophage activation. Mol Endocrinol 2005;19:2466-77.
78. Delerive P, Monte D, Dubois G et al. The orphan nuclear receptor ROR alpha is a negative regulator of the inflammatory response. Embo Reports 2001;2:42-8.
79. Besnard S, Silvestre JS, Duriez M et al. Increased ischemia-induced angiogenesis in the staggerer mouse, a mutant of the nuclear receptor Ror alpha. Circ Res 2001;89:1209-15.
80. Vaughan DE. PAI-1 and atherothrombosis. J Thromb Haemost 2005; 3:1879-83.
81. Wang J, Yin L, Lazar MA. The orphan nuclear receptor Rev-erb alpha regulates circadian expression of plasminogen activator inhibitor type 1. J Biol Chem 2006;281:33842-8.
82. Balsalobre A, Damiola F, Schibler U. A serum shock induces circadian gene expression in mammalian tissue culture cells [see comments]. Cell 1998;93:929-37.
83. Torra IP, Tsibulsky V, Delaunay F et al. Circadian and glucocorticoid regulation of Rev-erbalpha expression in liver. Endocrinology 2000;141: 3799-806.
84. Muhlbauer E, Wolgast S, Finckh U, Peschke D, Peschke E. Indication of circadian oscillations in the rat pancreas. FEBS Lett 2004;564:91-6.
85. Zvonic S, Ptitsyn AA, Conrad SA et al. Characterization of peripheral circadian clocks in adipose tissues. Diabetes 2006;55:962-70.
86. Yang X, Downes M, Yu RT et al. Nuclear receptor expression links the circadian clock to metabolism. Cell 2006;126:801-10.
87. Kaasik K, Lee CC. Reciprocal regulation of haem biosynthesis and the circadian clock in mammals. Nature 2004;430:467-71.
88. Le Minh N, Damiola F, Tronche F, Schutz G, Schibler U. Glucocorticoid hormones inhibit food-induced phase-shifting of peripheral circadian oscillators. EMBO J 2001;20:7128-36.
89. Lemberger T, Saladin R, Vazquez M et al. Expression of the peroxisome proliferator-activated receptor alpha gene is stimulated by stress and follows a diurnal rhythm. J Biol Chem 1996;271:1764-9.
90. Canaple L, Rambaud J, Dkhissi-Benyahya O et al. Reciprocal regulation of brain and muscle Arnt-like protein 1 and peroxisome proliferator-activated receptor alpha defines a novel positive feedback loop in the rodent liver circadian clock. Mol Endocrinol 2006;20:1715-7.
91. Inoue I, Shinoda Y, Ikeda M et al. CLOCK/BMAL1 is involved in lipid metabolism via transactivation of the peroxisome proliferator-activated receptor (PPAR) response element. J Atheroscler Thromb 2005;12: 169-74.